Barclays: Maintaining the Boston Scientific (BSX.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $70.00 to $78.00.
Zhitong FinanceApr 26 21:30
Redburn Atlantic Adjusts Price Target on Boston Scientific to $79 From $75
MT NewswiresApr 26 20:20
Barclays Reaffirms Their Buy Rating on Boston Scientific (BSX)
TipRanksApr 26 16:47
Citi: Maintains the Boston Scientific (BSX.US) rating, adjusted from buy to buy rating, and adjusted the target price from $79.00 to $85.00.
Zhitong FinanceApr 26 06:40
Boston Scientific Analyst Ratings
BenzingaApr 25 23:45
Wells Fargo: Maintaining the Boston Scientific (BSX.US) rating, adjusted from an increase in holdings to an increase rating, and the target price was adjusted from $72.00 to $82.00.
Zhitong FinanceApr 25 22:20
CL King Adjusts Boston Scientific's Price Target to $82 From $72
MT NewswiresApr 25 19:38
Boston Scientific (BSX) Receives a Buy From Truist Financial
TipRanksApr 25 19:10
Baird Maintains Outperform on Boston Scientific, Raises Price Target to $84
BenzingaApr 25 18:43
Mizuho Adjusts Price Target on Boston Scientific to $85 From $80
MT NewswiresApr 25 18:05
Boston Scientific (BSX) Poised for Growth: A Buy Recommendation Amid Strong Q1 Performance and Strategic Acquisitions
TipRanksApr 25 17:40
Boston Scientific: Strong Q1 Performance and Promising Future Drive Buy Rating
TipRanksApr 25 17:43
Needham: Maintaining the Boston Scientific (BSX.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $71.00 to $82.00.
Zhitong FinanceApr 25 05:50
Boston Scientific Analyst Ratings
BenzingaApr 25 05:44
Analysts' Opinions Are Mixed on These Healthcare Stocks: Boston Scientific (BSX) and CureVac (CVAC)
TipRanksApr 25 04:30
Citigroup Raises Boston Scientific's Price Target to $85 From $79
MT NewswiresApr 25 01:41
Piper Sandler Adjusts Price Target on Boston Scientific to $80 From $72, Maintains Overweight Rating
MT NewswiresApr 24 23:39
Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Boston Scientific (BSX) and Biogen (BIIB)
TipRanksApr 24 21:10
Royal Bank of Canada: Maintaining the Boston Scientific (BSX.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $70.00 to $78.00.
Zhitong FinanceApr 16 02:21
Boston Scientific Analyst Ratings
BenzingaApr 16 02:16
No Data
No Data